{"entity":{"type":"insider","cik":"0001591046","url":"/insider/0001591046","json_url":"/insider/0001591046.json","name":"Lundbeckfond Invest A/S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2014-02-06","last":"2023-11-09","span_basis":"filed_date"},"name_variants":[{"name":"Lundbeckfond Invest A/S","source":"filing","n_filings":6,"first_seen":"2014-02-06","last_seen":"2023-11-09"}],"transactions":[{"id":8296931,"accession":"0001209191-23-054907","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-054907","line_url":"/filing/0001209191-23-054907#line-3","is_derivative":false,"issuer_cik":"0001591046","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001591046","owner_cik":"0001591046","owner_name":"Lundbeckfond Invest A/S","owner_display_name":"Lundbeckfond Invest A/S","owner_url":"/insider/0001591046","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":227272.0,"shares_display":"227,272","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":2499992.0,"total_display":"2,499,992.00","total_whole":"2,499,992","shares_owned_after":1835959.0,"shares_owned_after_display":"1,835,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-07","filed_date":"2023-11-09","scope":"insider"},{"id":5355041,"accession":"0001140361-21-037653","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-21-037653","line_url":"/filing/0001140361-21-037653#line-3","is_derivative":false,"issuer_cik":"0001591046","issuer_name":"IO Biotech, Inc.","issuer_ticker":"IOBT","issuer_name_source":null,"issuer_url":"/issuer/0001591046","owner_cik":"0001591046","owner_name":"Lundbeckfond Invest A/S","owner_display_name":"Lundbeckfond Invest A/S","owner_url":"/insider/0001591046","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2142857.0,"shares_display":"2,142,857","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":29999998.0,"total_display":"29,999,998.00","total_whole":"29,999,998","shares_owned_after":6049452.0,"shares_owned_after_display":"6,049,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-09","filed_date":"2021-11-12","scope":"insider"},{"id":3111068,"accession":"0000899243-20-008479","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-008479","line_url":"/filing/0000899243-20-008479#line-2","is_derivative":false,"issuer_cik":"0001591046","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001591046","owner_cik":"0001591046","owner_name":"Lundbeckfond Invest A/S","owner_display_name":"Lundbeckfond Invest A/S","owner_url":"/insider/0001591046","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":1432722.0,"shares_owned_after_display":"1,432,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-16","scope":"insider"},{"id":8471414,"accession":"0000899243-19-013250","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-013250","line_url":"/filing/0000899243-19-013250#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001591046","owner_name":"Lundbeckfond Invest A/S","owner_display_name":"Lundbeckfond Invest A/S","owner_url":"/insider/0001591046","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375000.0,"shares_display":"375,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3750000.0,"total_display":"3,750,000.00","total_whole":"3,750,000","shares_owned_after":1151544.0,"shares_owned_after_display":"1,151,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-09","filed_date":"2019-05-13","scope":"insider"},{"id":4841774,"accession":"0000899243-17-027197","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-027197","line_url":"/filing/0000899243-17-027197#line-3","is_derivative":false,"issuer_cik":"0001591046","issuer_name":"scPharmaceuticals Inc.","issuer_ticker":"SCPH","issuer_name_source":null,"issuer_url":"/issuer/0001591046","owner_cik":"0001591046","owner_name":"Lundbeckfond Invest A/S","owner_display_name":"Lundbeckfond Invest A/S","owner_url":"/insider/0001591046","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":654762.0,"shares_display":"654,762","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":9166668.0,"total_display":"9,166,668.00","total_whole":"9,166,668","shares_owned_after":3183986.0,"shares_owned_after_display":"3,183,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-21","filed_date":"2017-11-21","scope":"insider"},{"id":6289733,"accession":"0001209191-14-007973","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-007973","line_url":"/filing/0001209191-14-007973#line-3","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Celladon Corp","issuer_ticker":"CLDN","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001591046","owner_name":"Lundbeckfond Invest A/S","owner_display_name":"Lundbeckfond Invest A/S","owner_url":"/insider/0001591046","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":182681.0,"shares_display":"182,681","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":1461448.0,"total_display":"1,461,448.00","total_whole":"1,461,448","shares_owned_after":1745683.0,"shares_owned_after_display":"1,745,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-04","filed_date":"2014-02-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001907108","name":"Lexeo Therapeutics, Inc.","url":"/issuer/0001907108","role":"Ten percent owner","n_filings":1,"first_seen":"2023-11-09","last_seen":"2023-11-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001865494","name":"IO Biotech, Inc.","url":"/issuer/0001865494","role":"Ten percent owner","n_filings":1,"first_seen":"2021-11-12","last_seen":"2021-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"IMARA Inc.","url":"/issuer/0001672619","role":"Ten percent owner","n_filings":1,"first_seen":"2020-03-16","last_seen":"2020-03-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001563880","name":"Trevi Therapeutics, Inc.","url":"/issuer/0001563880","role":"Ten percent owner","n_filings":1,"first_seen":"2019-05-13","last_seen":"2019-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001604950","name":"scPharmaceuticals Inc.","url":"/issuer/0001604950","role":"Ten percent owner","n_filings":1,"first_seen":"2017-11-21","last_seen":"2017-11-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001305253","name":"Celladon Corp","url":"/issuer/0001305253","role":"Ten percent owner","n_filings":1,"first_seen":"2014-02-06","last_seen":"2014-02-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001591046","retrieved_at":"2026-08-24T09:40:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}